Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-24-001491
Filing Date
2024-05-30
Accepted
2024-05-30 18:10:12
Documents
1
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240484861_4-forsyth.html 4  
1 OWNERSHIP DOCUMENT es240484861_4-forsyth.xml 4 6916
  Complete submission text file 0000950142-24-001491.txt   8464
Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address
FORSYTH DOUGLAS (Reporting) CIK: 0001240801 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241006990

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)